Completed
ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
NCT00490139
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- Novartis Investigative Site Mobile, Alabama, United States
- Novartis Investigative Site Anchorage, Alaska, United States
- Novartis Investigative Site Tucson, Arizona, United States
- Novartis Investigative Site Jonesboro, Arkansas, United States